Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 4/20 | 0.38 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.36 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 4/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | ATG7 | O95352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27086454 | 0.90 | PDE2A (0.37) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL31063739 | 0.90 | PDE2A (0.37) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL12243141 | 0.90 | PDE2A (0.37) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL12393373 | 0.90 | PDE2A (0.37) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL18636484 | 0.89 | PDE2A (0.39) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL29113115 | 0.89 | PDE2A (0.39) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL31725309 | 0.86 | PDE2A (0.36) | PDE2AHSPA5TNK2RIPK1 | |
| SCHEMBL13667906 | 0.86 | HSPA5 (0.38) | PDE2AHSPA5TNK2HTR1A | |
| SCHEMBL23278052 | 0.83 | HSPA5 (0.36) | PDE2AHSPA5TNK2RIPK1 | |
| SCHEMBL23818461 | 0.82 | TNK2 (0.34) | HSPA5TNK2RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235664-A1 | PURINE NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2025-11-13 | — | — | WO | disclosed |